Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
50% from low
Exchange
OTC Link
OS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $369.1K | $513.0K | $589.8K | $1.4M | $606.4K | $4.1M | $37.7K |
| Cost of revenue | $0 | $423.8K | $429.9K | $467.9K | $10.4K | $0 | $1.2M | $1.2M |
| Gross profit | $0 | −$54.7K | $83.1K | $122.0K | $1.4M | $606.4K | $2.8M | −$1.2M |
| Gross margin | — | -14.8% | 16.2% | 20.7% | 99.3% | 100.0% | 69.6% | -3150.2% |
| R&D | $1.4M | $841.0K | $783.8K | $946.8K | $2.0M | $2.0M | $1.2M | $1.2M |
| Operating income | −$2.8M | −$2.6M | −$3.0M | −$5.2M | −$6.2M | −$5.2M | −$858.0K | −$4.8M |
| EBITDA | −$2.8M | −$2.5M | −$2.9M | −$5.2M | −$4.8M | −$4.5M | $438.2K | −$3.5M |
| Net income | −$2.8M | −$2.6M | −$3.0M | −$5.3M | −$3.5M | −$4.1M | $698.4K | −$3.0M |
| Net margin | — | -697.0% | -583.0% | -899.9% | -244.3% | -669.0% | 17.1% | -7846.5% |
| EPS (diluted) | -0.07 | -0.06 | -0.07 | -0.10 | -0.06 | -0.07 | 0.01 | -0.04 |
Annual figures · source: Financial Modeling Prep
BIOASIS TECHNOLOGIES INC
No one on the platform currently holds BIOAF.
No tracked institution reports a position in BIOAF as of their last filing.
No one on the platform has traded BIOAF yet.
| $162828 |
| — |
| GSTCGlobeStar Therapeutics Corporation | $0.00 | +0.00% | $124111 | — |
| IRBSIR Biosciences Holdings Inc. | $0.00 | +0.00% | $128122 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$BIOAF someone is really manipulating this little known stock
View on StockTwits ↗$BIOAF, new management! Big announcement coming!? Whoop whoop just load.
View on StockTwits ↗$BIOAF Bioasis Provides Corporate Update and Announces Suspension of Operations https://www.stocktitan.net/news/BIOAF/bioasis-provides-corporate-update-and-announces-suspension-of-5a7rkiw3y6m8.html
View on StockTwits ↗$BIOAF Bioasis Provides Update on Business Operations https://www.stocktitan.net/news/BIOAF/bioasis-provides-update-on-business-3vs6slwvc6sb.html
View on StockTwits ↗$BIOAF Bioasis Announces AGM Results and Provides Update on Financial Position https://www.stocktitan.net/news/BIOAF/bioasis-announces-agm-results-and-provides-update-on-financial-0odudf1ti105.html
View on StockTwits ↗Bioasis Technologies Sees Short Interest Decrease from 73,600 shares to 25,100 shares. $BIOAF https://www.marketbeat.com/stocks/OTCMKTS/BIO
View on StockTwits ↗$BIOAF Bioasis Technologies Inc. Announces Termination of Arrangement Agreement with Midatech Pharma plc https://www.stocktitan.net/news/BIOAF/bioasis-technologies-inc-announces-termination-of-arrangement-lc9irq1h20yz.html
View on StockTwits ↗$BIOAF Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2022 https://www.stocktitan.net/news/BIOAF/bioasis-announces-filing-of-its-quarterly-financial-statements-and-39fkypkgskn2.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.